. 2016 Sep 23;13(10):939. doi: 10.3390/ijerph13100939

Table 4.

Distribution of genotypes and ORs for adenocarcinoma cases and cancer-free controls.

SNP	Genotype	Controls (%)	Adenocarcinoma (%)	Adjusted OR ^a	95% CI	p
SNP	Genotype	N = 395	N = 321	Adjusted OR ^a	95% CI	p
rs7813	TT	153 (38.7)	170 (53.0)	Ref
	CT	193 (48.9)	118 (36.8)	0.550	0.401, 0.755	<0.001 *
	CC	49 (12.4)	33 (10.3)	0.595	0.362, 0.976	0.040 *
Dominant model	CT + CC	242 (61.3)	151 (47.0)	0.562	0.417, 0.757	<0.001 *
Additive model	C allele			0.689	0.551, 0.862	0.001 *
rs2740349	AA	298 (75.4)	259 (80.7)	Ref
	AG	86 (21.8)	59 (18.4)	0.788	0.543, 1.141	0.207
	GG	11 (2.8)	3 (0.9)	0.313	0.086, 1.134	0.077
Dominant model	AG + GG	97 (24.6)	62 (19.3)	0.734	0.512, 1.052	0.093
Additive model	G allele			0.711	0.513, 0.987	0.041 *
rs2291778	GG	214 (54.2)	150 (46.7)	Ref
	GT	150 (38.0)	134 (41.7)	1.275	0.932, 1.745	0.128
	TT	31 (7.8)	37 (11.5)	1.719	1.017, 2.904	0.043 *
Dominant model	GT + TT	181 (45.8)	171 (53.3)	1.354	1.006, 1.821	0.045 *
Additive model	T allele			1.307	1.040, 1.642	0.021 *
rs910924	CC	277 (70.1)	261 (81.3)	Ref
	CT	108 (27.3)	55 (17.1)	0.540	0.374, 0.779	0.001 *
	TT	10 (2.5)	5 (1.6)	0.533	0.180, 1.582	0.257
Dominant model	CT + TT	118 (29.9)	60 (18.7)	0.540	0.379, 0.769	0.001 *
Additive model	T allele			0.583	0.424, 0.802	0.001 *
rs595961	GG	285 (72.2)	198 (61.7)	Ref
	AG	102 (25.8)	112 (34.9)	1.580	1.143, 2.184	0.006 *
	AA	8 (2.0)	11 (3.4)	1.982	0.783, 5.018	0.149
Dominant model	AG + AA	110 (27.8)	123 (38.3)	1.609	1.175, 2.205	0.003 *
Additive model	A allele			1.502	1.143, 1.974	0.003 *

^a Adjusted for age, ORs and 95% CIs were calculated by logistic regression; * p < 0.05. Bold values indicate significance after Bonferroni correction (k = 8).